H.I.G. BioHealth Partners invests in a broad range of life science companies across multiple sectors and stages of development.
Business Model:
Revenue: $10M
Employees: 2-10
Address: 1450 Brickell Ave
City: Miami
State: FL
Zip: 33131
Country: US
H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Their seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. They invest in companies developing novel products for significant unmet medical needs.
Contact Phone:
+13053792322
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
3/2018 | On Target Laboratories | Series B | 0 |
3/2017 | VertiFlex | Equity | 45.3M |
6/2015 | RxSIGHT | Debt Financing | 17M |
1/2017 | Intact Vascular | Series B | 0 |
8/2016 | Nutrinia | Series D | 30M |
5/2015 | NeuWave Medical | Series C | 25.3M |
9/2012 | Intact Vascular | Series A | 15.5M |
5/2019 | Intact Vascular | Series D | 0 |
7/2019 | Exagen | Venture Round | 0 |
5/2018 | Neurana Pharmaceuticals | Series A | 0 |
4/2018 | Intact Vascular | Series C | 0 |
6/2015 | RxSIGHT | Venture Round | 52M |
4/2015 | Cardeas Pharma | Series B | 37.5M |
2/2019 | Arvelle Therapeutics | Series A | 0 |
5/2015 | Intact Vascular | Series B | 0 |
10/2021 | Click Therapeutics | Series B | 0 |
4/2014 | Iconic Therapeutics | Series B | 20M |
6/2018 | Iconic Therapeutics | Venture Round | 0 |
8/2016 | Iconic Therapeutics | Series C | 10M |
8/2015 | Orbus Therapeutics | Series A | 32.5M |
4/2014 | ForSight VISION5 | Equity | 15M |
4/2014 | ForSight Labs | Series C | 15M |
10/2019 | Zerigo Health | Series A | 0 |
10/2012 | Cerephex | Series A | 5.9M |
8/2012 | NeuWave Medical | Equity | 14M |
5/2020 | Arvelle Therapeutics | Series A | 0 |
10/2021 | Click Therapeutics | Series B | 0 |
5/2020 | Arvelle Therapeutics | Series A | 0 |
10/2019 | Zerigo Health | Series A | 0 |
7/2019 | Exagen | Venture Round | 0 |
5/2019 | Intact Vascular | Series D | 0 |
2/2019 | Arvelle Therapeutics | Series A | 0 |
6/2018 | Iconic Therapeutics | Venture Round | 0 |
5/2018 | Neurana Pharmaceuticals | Series A | 0 |
4/2018 | Intact Vascular | Series C | 0 |
3/2018 | On Target Laboratories | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|